GME Capital »

Vertex Pharmaceuticals Incorporated shares owned by GME Capital

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by GME Capital from 13F filings

Historical chart of GME Capital investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by GME Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by GME Capital

Quarter filed Position value Share count Share price at filing
2011-06-30 $2.6M 51k 51.99
2011-03-31 $2.4M 51k 47.93
2010-12-31 $1.8M 51k 35.03

More positions owned by GME Capital

Celgene Corporation
Southwestern Energy Company
Continental Resources
3D Systems Corporation (DDD)
Analog Devices (ADI)
International Business Machines (IBM)
Stericycle (SRCL)
Goldcorp
VirnetX Holding Corporation
EQT Corporation (EQT)
Central Fd Cda Ltd cl a
Xerox Corporation
Quidel Corporation
Thermo Fisher Scientific (TMO)
Pfizer (PFE)

View all positions for GME Capital

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
State Street Corporation
Jpmorgan Chase & Co
Geode Capital Management
Wellington Management Company
Capital Research and Management Company - Division 3
Alliancebernstein
Loomis, Sayles and
Jennison Associates
Morgan Stanley
FMR
Ubs Global Asset Management Americas

View all funds holding Vertex Pharmaceuticals Incorporated